Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Meningioma peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Meningioma. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
2 profiles.
2023–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 16 selected PubMed records and 4 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Meningioma unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03953131
PeptideScanner retained ClinicalTrials.gov record NCT03953131 at 2026-11-16T17:36:42.191Z. Its registry update date was 2023-09-01, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 1, 2023
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03971461
PeptideScanner retained ClinicalTrials.gov record NCT03971461 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 29, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05278208
PeptideScanner retained ClinicalTrials.gov record NCT05278208 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- July 20, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Lutetium Lu 177 dotatate · 2026-11-16
ClinicalTrials.gov record NCT05278208
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-09-29
ClinicalTrials.gov record NCT03971461
Active, not recruiting at the retained observation.
Open attributed record →Gallium Ga 68 dotatate · 2023-09-01
ClinicalTrials.gov record NCT03953131
Completed at the retained observation.
Open attributed record →